FEAR IS JUST AN ILLU... • 10d
A market of 1.3 billion people exists in neurological recovery. The harsh reality is that fewer than 20% receive meaningful therapy. This leaves an untapped, underserved population of over a billion individuals. I am building the company that will solve it. We've created a new paradigm: a closed-loop system where the brain, AI, and VR sync to accelerate healing. Our TRL-5 prototype is working and our 7-clinic pilot is ready. This is the foundation for the world's first trillion-dollar health-tech company. I am not hiring an employee. I'm bringing on a Founding Partner & Head of Strategy to build this empire with me. Your first objective: lead our ₹1.5 Cr pre-seed round at a ₹15 Cr valuation and architect the financial roadmap for a revolution. This is for a proven leader who has scaled ventures and commands the attention of investors. If the scale of this ambition excites you, you are the partner I’m looking for. Send me a direct message. Let's start the conversation.
•
Helixworks Technologies • 6m
From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power
See MoreA JV between Apollo ... • 1m
Global Standards, Local Expertise: The Reach of Expert Neuro Rehabilitation Key Takeaways: Neurological conditions affect millions globally, creating a universal need for specialized rehabilitation. Expert neuro rehabilitation centers adhere to high
See MoreDownload the medial app to read full posts, comements and news.